Hi LordGoat,
Thanks, I'm aware of what the plan is from the SPP, and I give it a high chance we will raise $27.9M for the full case.
My question is: in the unlikely event (imo) what IF we did not reach the full case, what is the management's plan regarding Phase 2 EMD AML/MDS clinical trial in Europe?
As stated in the SPP this trial is contingent on raising the full $27.9M (full case).
I suspect the management will seek raising the shortfall from instos to fund the trial in Europe asap, not leaving it to chance and wait for the $4.5 oppies.
Perhaps too early for Dr. T to be commenting on this. In the meantime, I have all my fingers crossed that the SPP will be a huge success.
Ann: Race Oncology Share Purchase Plan Opens, page-409
-
- There are more pages in this discussion • 149 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.54 |
Change
-0.015(0.97%) |
Mkt cap ! $261.5M | |||
| Open | High | Low | Value | Volume |
| $1.55 | $1.55 | $1.50 | $111.4K | 73.35K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $1.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.56 | 1400 | 1 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |